Marketplace®

Daily business news and economic stories

India rejects Novartis cancer drug patent

The Supreme Court in India has rejected an attempt by the Swiss drug maker Novartis to patent an update to a cancer treatment.

The Supreme Court in India has rejected an attempt by the Swiss drug maker Novartis to patent an update to a cancer treatment called Gleevec — spelled Glivec in some markets. The decision is expected to have a big impact on pharmaceutical companies and health organizations far outside the borders of India.

The BBC’s Rahul Tandon joins Marketplace Morning Report host Jeremy Hobson to discuss the global pharmaceutical market and the new patent ruling.

Related Topics

Latest Episodes

View All Shows
  • Marketplace
    9 hours ago
    26:16
  • Make Me Smart
    13 hours ago
    15:45
  • Marketplace Morning Report
    16 hours ago
    6:33
  • Marketplace Tech
    21 hours ago
    10:28
  • Million Bazillion
    2 days ago
    28:24
  • How We Survive
    5 days ago
    25:04
  • This Is Uncomfortable
    6 days ago
    26:12
  • Financially Inclined
    3 months ago
    12:30
  • The Uncertain Hour
    4 months ago
    22:50
  • Corner Office from Marketplace
    5 years ago
    20:58